Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Pazopanib in Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Pazopanib in Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01361113).
- Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2: primary endpoint results, effect estimate…
- Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00887575).
- Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00828308).
- Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03096418).
- NEOARTIndependent statistical analysis of A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring…
- NeoChord TACT Post-Market Surveillance Registry: Complete Statistical AnalysisIndependent statistical analysis of NeoChord TACT Post-Market Surveillance Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01784055).
- Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN: Complete Statistical AnalysisIndependent statistical analysis of Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NeoFINDIndependent statistical analysis of [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NeohttpIndependent statistical analysis of Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02345772).
- NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test: Complete Statistical AnalysisIndependent statistical analysis of NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03522675).
- NEOMUNIndependent statistical analysis of Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03197467).
- Neonatal Intensive Care Unit Virtual Family-Centered Rounds: Complete Statistical AnalysisIndependent statistical analysis of Neonatal Intensive Care Unit Virtual Family-Centered Rounds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05762835).
- Neonatal Outcome by Reason for Delivery: Complete Statistical AnalysisIndependent statistical analysis of Neonatal Outcome by Reason for Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01818518).
- Neonatal Warming to Prevent Hypothermia: Complete Statistical AnalysisIndependent statistical analysis of Neonatal Warming to Prevent Hypothermia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04827394).
- NeoPHOEBEIndependent statistical analysis of NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NeoResIndependent statistical analysis of Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NeoSTOPIndependent statistical analysis of Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NeoSTOP-ITIndependent statistical analysis of Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NEOSURFIndependent statistical analysis of Comparison of Curosurf and Infasurf in the Treatment of Preterm Infants With Respiratory Distress Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NEOTHROCOVIDIndependent statistical analysis of Thromboembolic Risk Screening in Patients With Cancer and COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04616846).
- NEPALIndependent statistical analysis of A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- NEPTUNEIndependent statistical analysis of Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE): primary endpoint results, effect estimate with confidence interval, sample-size…
- Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer: primary endpoint results, effect estimate with…
- Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain: Complete Statistical AnalysisIndependent statistical analysis of Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nesiritide Use Following Cardiac Surgery in Infants: Complete Statistical AnalysisIndependent statistical analysis of Nesiritide Use Following Cardiac Surgery in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00281671).
- NESTIndependent statistical analysis of Nitrous Oxide for Pain Management During In-office Transcervical Sterilization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02312739).
- NEST-1Independent statistical analysis of Combination Immunotherapy in Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05571293).
- NeSTSIndependent statistical analysis of Median Nerve Stimulation for Tourette Syndrome and Chronic Tic Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05269953).
- Network Support for Alcohol Treatment 2: Complete Statistical AnalysisIndependent statistical analysis of Network Support for Alcohol Treatment 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01129804).
- NeuCLAIndependent statistical analysis of Neural Correlates of Lidocaine Analgesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05501600).
- NeuHFRecoverIndependent statistical analysis of NMES in HF Patients to Improve Functional Recovery Following Hospitalization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05338437).
- NEUPADIndependent statistical analysis of Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Neural Bases of Cognitive Rehabilitation for Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Neural Bases of Cognitive Rehabilitation for Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01120756).
- Neural Facilitation of Movements in People With SCI: Complete Statistical AnalysisIndependent statistical analysis of Neural Facilitation of Movements in People With SCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05354206).
- Neural Mechanisms Associated With Risk of Smoking Relapse: Complete Statistical AnalysisIndependent statistical analysis of Neural Mechanisms Associated With Risk of Smoking Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02837510).
- Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder: Complete Statistical AnalysisIndependent statistical analysis of Neural Response to Food Stimuli: fMRI Changes Following Cognitive Behavioral Therapy for Binge Eating Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Neural Substrates in Nicotine Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Neural Substrates in Nicotine Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01001520).
- Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery: Complete Statistical AnalysisIndependent statistical analysis of Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04017442).
- Neurobiological Bases of Placebo Response in Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Neurobiological Bases of Placebo Response in Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01787240).
- Neurobiological Similarities of Tinnitus and PTSD: Complete Statistical AnalysisIndependent statistical analysis of Neurobiological Similarities of Tinnitus and PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05981391).
- Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders: Complete Statistical AnalysisIndependent statistical analysis of Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01720316).
- Neurocognitive Benefits of a Weight Management Program: Complete Statistical AnalysisIndependent statistical analysis of Neurocognitive Benefits of a Weight Management Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04202133).
- Neurocognitive Factors in EdTech Intervention Response: Complete Statistical AnalysisIndependent statistical analysis of Neurocognitive Factors in EdTech Intervention Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04568824).
- NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis: Complete Statistical AnalysisIndependent statistical analysis of NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04638673).
- Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants: Complete Statistical AnalysisIndependent statistical analysis of Neurodevelopmental and Growth Outcomes of Early, Aggressive Protein Intake in Very Low Birthweight Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…